<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome in association with pulmonary abnormalities is rare </plain></SENT>
<SENT sid="1" pm="."><plain>We described a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome who had pulmonary involvement </plain></SENT>
<SENT sid="2" pm="."><plain>A review of the literature disclosed 12 similar cases </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0004418'>Thrombophlebitis</z:hpo>, <z:e sem="disease" ids="C0038833" disease_type="Disease or Syndrome" abbrv="">superior vena cava obstruction</z:e>, and <z:hpo ids='HP_0002105'>hemoptysis</z:hpo> are characteristic clinical features of patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome and <z:hpo ids='HP_0002113'>pulmonary infiltrates</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Once diffuse <z:e sem="disease" ids="C0235896" disease_type="Disease or Syndrome" abbrv="">pulmonary infiltration</z:e> and massive <z:hpo ids='HP_0002105'>hemoptysis</z:hpo> appear, the prognosis is poor; <z:hpo ids='HP_0011420'>death</z:hpo> from pulmonary exsanguination is likely to occur </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and <z:chebi fb="0" ids="8382">prednisone</z:chebi>, in addition to blood transfusions, may be beneficial </plain></SENT>
</text></document>